Searched for
KIRAN S DIVI
Latest Malayalam, Tamil, Telugu, Kannada OTT releases: Karuppu to Dridam, new movies and shows on Netflix, JioHotstar, Prime VideoSouth OTT releases have an exciting lineup this week, with several new movies and shows arriving on June 12. From the Malayalam mystery thr...
Sell Divi's Laboratories, target price Rs 4,500: ICICI SecuritiesICICI Securities recommends a sell on Divi's Laboratories with a target price of Rs 4,500 despite recent quarterly growth. Management remai...
Buy Divi's Laboratories, target price Rs 3730: ICICI SecuritiesDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 94466.99 Crore) operating in Pharmace...
Buy Divi's Laboratories, target price Rs 2912: ICICI DirectDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 76314.25 Crore) operating in Pharmace...
Motilal Oswal Financial Services neutral on Divi's Laboratories, target price-Rs 2620Promoters held 51.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 15.15 per cent, DIIs 20.5 per cent.
Sell Divi's Laboratories, target price Rs 2750: Sharekhan by BNP ParibasDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 75747.48 Crore) operating in Pharmace...
Buy Divi's Laboratories, target price Rs 3480: Reliance SecuritiesDivi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 90499.57 Crore) operating in Pharmace...
Divi's Lab seeks shareholders' nod for re-appointment of Kiran S Divi as CEOThe shares of the company were trading at Rs 1,927 piece on BSE.
Buy Divi's Laboratories, target Rs 1,680: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1680.0 and a stoploss at Rs 1590 from entry point.
Buy Divi's Laboratories, target Rs 1,724: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1724.0 and a stoploss at Rs 1677 from entry point.
Buy Divi's Laboratories, target Rs 1610: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1610.0 and a stoploss at Rs 1500 from entry point.
Sell Divi's Laboratories, target Rs 1,400: Kunal BothraSell Divi's Laboratories Ltd. at a price target of Rs 1400.0 and a stoploss at Rs 1455 from entry point.
Buy Divi's Lab, target Rs 1220: Dr CK NarayanBuy Divi's Laboratories Ltd. at a price target of Rs 1220 and a stop loss at Rs 1185 from entry point.
- Buy Divi's Laboratories, target Rs 1,150: Kunal Bothra
Buy Divi's Laboratories Ltd. at a price target of Rs 1150.0 and a stop loss at Rs 1060 from entry point.
- Buy Divi's Laboratories, target Rs 1,100: Kunal Bothra
Buy Divi's Laboratories Ltd. at a price target of Rs 1100.0 and a stop loss at Rs 1040 from entry point.
- Buy Divi's Laboratories, target Rs 1,090: Shrikant Chouhan
Buy Divi's Laboratories Ltd. at a price target of Rs 1090.0 and a stop loss at Rs 1030 from entry point.
- Sell Divi's Laboratories, target Rs 1,059.30: ICICI Direct
Sell Divi's Laboratories Ltd. at a price target of Rs 1059.3 and a stop loss at Rs 1090.2 from entry point.
- Buy Divi's Laboratories, target Rs 1,225: Nagaraj Shetti
Buy Divi's Laboratories Ltd. at a price target of Rs 1225.0 and a stop loss at Rs 1015 from entry point.
- Buy Divi's Laboratories, target Rs 920: Chandan Taparia
Buy Divi's Laboratories at a price target of Rs 920 and a stop loss at Rs 860 from entry point.
- Sell Divi's Laboratories, target Rs 900: Kunal Bothra
Sell Divi's Laboratories Ltd. at a price target of Rs 900.0 and a stoploss at Rs 1044 from entry point.